Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)

SHE:002864 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	1,157	1,095	1,169	1,102	823.44	419.3
Cash & Short-Term Investments	1,157	1,095	1,169	1,102	823.44	419.3
Cash Growth	-0.66%	-6.37%	6.11%	33.83%	96.38%	9.77%
Accounts Receivable	450.6	547.28	494.59	476.42	538.41	446.38
Other Receivables	27.77	10.07	2.12	3.07	2.13	2.55
Receivables	478.37	557.35	496.71	479.49	540.54	448.93
Inventory	108.17	110.82	95.58	77.63	94.63	66.77
Other Current Assets	13.36	39.71	9.86	18.67	23.33	21.45
Total Current Assets	1,757	1,803	1,772	1,678	1,482	956.45
Property, Plant & Equipment	429.01	439.04	438.21	371.7	353.74	275.04
Long-Term Investments	9.9	10.08	10.21	9.71	9.89	-
Other Intangible Assets	49.01	50.13	51.35	52.76	54.9	56.33
Long-Term Deferred Tax Assets	23.16	9.35	4.89	7.22	16.63	20.2
Long-Term Deferred Charges	6.34	4.39	3.12	2.87	1.31	0.02
Other Long-Term Assets	7.03	7.03	0.71	2.96	12.36	22.13
Total Assets	2,281	2,323	2,280	2,125	1,931	1,330

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	97.7	127.57	107.92	91.43	121.67	66.01
Accrued Expenses	10.42	194.74	187.96	181.38	215.43	176.72
Short-Term Debt	-	-	50	100	150.46	87.2
Current Portion of Long-Term Debt	0.61	98.5	1	-	247.62	13
Current Portion of Leases	-	0.38	0.31	0.39	1.41	2.03
Current Income Taxes Payable	32.72	10.52	8.66	9.11	14.73	17.21
Current Unearned Revenue	8.71	4.21	3.68	5.53	13.26	4.7
Other Current Liabilities	313.18	88.23	86.59	92.57	138.11	70.69
Total Current Liabilities	463.35	524.15	446.11	480.41	902.68	437.55
Long-Term Debt	1	-	98.5	-	27.35	40.35
Long-Term Leases	1.55	1.95	2.33	2.11	0.33	1.32
Long-Term Unearned Revenue	108.98	107.65	95.9	91.25	52.83	41.4
Long-Term Deferred Tax Liabilities	-	-	-	-	-	2.35
Total Liabilities	574.88	633.75	642.84	573.76	983.18	522.97

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	136.7	106.28	106.28	106.28	86.71	86.67
Additional Paid-In Capital	765.11	813.9	816.64	817.78	259.43	271.67
Retained Earnings	808.34	791.73	737.25	640.06	548.96	463.19
Treasury Stock	-5.81	-25.08	-24.95	-15.07	-15.07	-30.15
Comprehensive Income & Other	-	-	-	-	49.62	-
Total Common Equity	1,704	1,687	1,635	1,549	929.65	791.38
Minority Interest	2.09	2.2	1.97	2.21	17.95	15.82
Shareholders' Equity	1,706	1,689	1,637	1,551	947.6	807.21
Total Liabilities & Equity	2,281	2,323	2,280	2,125	1,931	1,330

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	3.16	100.83	152.14	102.49	427.16	143.9
Net Cash (Debt)	1,154	994.06	1,017	999.52	396.28	275.41
Net Cash Growth	13.81%	-2.28%	1.77%	152.22%	43.89%	-1.78%
Net Cash Per Share	8.44	7.31	7.48	7.87	3.53	2.48
Filing Date Shares Outstanding	140.35	137.68	137.68	136.7	124.54	111.21
Total Common Shares Outstanding	140.35	137.68	137.68	136.7	111.26	111.21
Working Capital	1,294	1,279	1,325	1,197	579.27	518.89
Book Value Per Share	12.14	12.25	11.88	11.33	8.36	7.12
Tangible Book Value	1,655	1,637	1,584	1,496	874.75	735.05
Tangible Book Value Per Share	11.79	11.89	11.50	10.95	7.86	6.61
Buildings	-	447.01	398.37	331.9	329.36	152.82
Machinery	-	176.05	144.4	134.72	125.41	60.38
Construction In Progress	-	6.75	56.05	29.31	3.85	152.18

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error